Current treatment of acute lymphoblastic leukemia in adults

Der Internist
N Gökbuget

Abstract

Acute lymphoblastic leukemia (ALL) is the most frequent malignant disease in childhood. In adults ALL comprises approximately 20 % of all forms of acute leukemia. In recent years substantial progress has been made with respect to the characterization and therapy optimization based on consecutive therapy optimization studies with increasingly more individualized, risk-adapted therapy protocols. Approximately 90 % of adult ALL patients under 55-65 years can now achieve complete remission. The chance of cure for adults could be increased over the last 30 years from less than 10 % to more than 50 %. Fundamental for the improvement of therapy results were an optimization of intensive chemotherapy and supportive treatment, integration of stem cell transplantation into the first-line treatment, inclusion of targeted substances in the therapy concept and improved risk stratification in consideration of the course of the minimal residual disease. Due to individualized therapeutic decisions current therapy protocols are very complex and can only be adequately carried out in specialized centers. Future challenges include further optimization of therapy in older patients and treatment of patients refractory to chemotherapy. In Germany the ...Continue Reading

References

Dec 23, 2008·Seminars in Hematology·Nicola Gökbuget, Dieter Hoelzer
Jan 9, 2009·The New England Journal of Medicine·Charles G MullighanUNKNOWN Children's Oncology Group
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Renato Bassan, Dieter Hoelzer
Oct 15, 2011·The New England Journal of Medicine·Lisa Diller
Feb 1, 2012·Seminars in Oncology·Monika BrüggemannMichael Kneba
Mar 24, 2012·Blood·Nicola GökbugetUNKNOWN German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia
Apr 12, 2012·Blood·Nicola GökbugetUNKNOWN German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia
May 16, 2013·Blood·Nicola Gökbuget
May 23, 2014·Animal : an International Journal of Animal Bioscience·S T Butler
Sep 11, 2014·The New England Journal of Medicine·Kathryn G RobertsCharles G Mullighan
Oct 16, 2014·The New England Journal of Medicine·Shannon L MaudeStephan A Grupp
Nov 2, 2014·Blood·Dieter HoelzerUNKNOWN German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia

❮ Previous
Next ❯

Citations

Jan 4, 2018·Blood Advances·Elias Jabbour, Hagop Kantarjian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Reviews in Clinical and Experimental Hematology
N Gökbuget, D Hoelzer
Seminars in Hematology
N Gökbuget, D Hoelzer
Annals of Hematology
N GökbugetD Hoelzer
International Journal of Hematology
Masamitsu Yanada, Tomoki Naoe
© 2021 Meta ULC. All rights reserved